Chungui International BioTech Group has filed for an initial public offering. The consumer goods company said it will sell 3 million units at $5 apiece, according to a filing with the Securities and ...

The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest ...

Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of biotechs chipping away at 2025’s iced-over IPO market. The Belgium-based ...

Indian vaccine developer Bharat Biotech International Ltd is considering an initial public offering that may raise more than ...

US biotech Generate Biomedicines (Nasdaq: GENB) raised $400 million in its initial public offering, selling 25 million shares at $16 each, the midpoint of its range. It marks the largest biotech IPO ...

Bharat Biotech is considering a $500 million IPO, aiming to expand its vaccine portfolio. Learn about its global impact and market outlook.

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

Biotech IPOs fell to a decade low in 2025 Investors expect more listings amid easing rate pressure Policy clarity under Trump has reduced worst-case fears Late-stage drug pipelines drawing renewed ...

EIR Biopharma is hoping to bring in $17.1 million from an IPO on the New York Stock Exchange that could fund development of its preclinical eye disease drug. The San Francisco-headquartered company is ...

The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering that could raise over $500 million, according to sources cited by multiple reports.Discussions are ...

Hair loss remains an area lacking biotechnology innovation. The drugs currently available are older products offering limited efficacy. Some of them cannot be used by women. Veradermics aims to shake ...

While the first couple months of the year brought a steady stream of market entries from companies in sectors such as construction tech, space tech and biotech, new offerings from SaaS companies, long ...